The frequencies of CD4+ CD44+ CD62L+ and CD8+ CD44+ CD62L+ presumed that central memory T cells were not altered in the lung by MBV treatment at day 21 after infection (P > 0.05; Fig. 4C). This evidence concerns the gene SELL and infection.